There are several ways to support the QiC Programme, and partners have the opportunity to help develop the programme alongside NHS and patient group experts.
QiC partners will benefit from exclusive networking opportunities with experts in the therapy area landscape over the lifecycle of each award programme.
"Sanofi is pleased to support the QiC Programme in 2018 and to recognise those individuals, teams, Trusts and partnerships who demonstrate quality in care for their diabetes patients. We’re keen to see evidence of quality improvement which aligns with current NHS priorities including the diabetes transformation funding which aims to increase structured education, improve achievement of NICE treatment targets, reduce the number of amputations and length of hospital stays for people with diabetes."
Professor Mike Baxter, Diabetes Therapy Lead, Sanofi Medical